1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 149 F.Supp.2d
  5. 149 F.Supp.2d 659 (2001)
 

ELI LILLY AND CO. v. ZENITH GOLDLINE PHARMACEUTICALS

No. IP 99-38-C H/G.

149 F.Supp.2d 659 (2001)

ELI LILLY AND COMPANY, Plaintiff, v. ZENITH GOLDLINE PHARMACEUTICALS, INC., Defendant.

United States District Court, S.D. Indiana, Indianapolis Division.

July 6, 2001.

Attorney(s) appearing for the Case

Ronald L. Grudziecki, R. Danny Huntington, Brian P. O'Shaughnessy, Burns, Doane, Zwecker Mathis, LLP, Alexandria, VA, Jan M. Carroll, Barnes & Thornburg, Indianapolis, IN, for plaintiff.

William L. Mentlik, Roy H. Wepner, Paul H. Wepner, Paul H. Kochanski, Michael H. Teschner, Lerner, David, Littenberg, Krumholz & Mentlik, LLP, Westfiled, NJ, Stephen E. Arthur, Harrison & Moberly, Indianapolis, IN, for defendant.

ENTRY ON PLAINTIFF'S MOTION TO COMPEL AND DEFENDANT'S MOTION FOR PROTECTIVE ORDER

HAMILTON, District Judge.

Plaintiff Eli Lilly and Company has sued defendant Zenith Goldline Pharmaceuticals, Inc. for infringing U.S.Patent No. 4,375,547. The '547 patent claims a compound called nizatidine, the active agent in Lilly's gastric antisecretory product called "Axid." On October 6, 1998, defendant Zenith amended its previously filed abbreviated new drug application...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases